These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 13631330)

  • 1. A micromethod of euglobulin fibrinolysis in plasma of human subjects and small laboratory animals.
    COPLEY AL; NIEWIAROWSKI S; MARECHAL J
    J Lab Clin Med; 1959 Mar; 53(3):468-73. PubMed ID: 13631330
    [No Abstract]   [Full Text] [Related]  

  • 2. An evaluation of the euglobulin method for the determination of fibrinolysis.
    KOWALSKI E; KOPEC M; NIEWIAROWSKI
    J Clin Pathol; 1959 May; 12(3):215-8. PubMed ID: 13654539
    [No Abstract]   [Full Text] [Related]  

  • 3. PLASMA EUGLOBULIN LYSIS TIME IN SOME SPECIES OF ANIMALS.
    RAO AR; GOPALAN C
    Indian J Med Res; 1964 Dec; 52():1287-92. PubMed ID: 14264202
    [No Abstract]   [Full Text] [Related]  

  • 4. Fibrinolysis in the pigeon (Columba livia).
    Ahmad N; Dube B; Agarwal GP; Dube R
    Thromb Haemost; 1979 Oct; 42(3):955-8. PubMed ID: 505408
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Separation of the fibrinolytic substances in euglobulin solution of man and dog plasma by gel filtration using Sephadex G-100 and 200.
    Nitta H; Sugie I; Sato S; Morimoto S; Miyachi S
    Nagoya Med J; 1967 Mar; 13(1):23-32. PubMed ID: 6075636
    [No Abstract]   [Full Text] [Related]  

  • 6. [Index of fibrinolysis with new fibrin plate (author's transl)].
    Hishikawa Y; Sugie I
    Nihon Seirigaku Zasshi; 1977; 39(1):1-11. PubMed ID: 140239
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [On euglobulin fibrinolysis. II. The characteristics of euglobulin fibrinolysis in arterisclerotic subjects].
    CAMERADA P; CONGIU M; LEO P
    Boll Soc Ital Biol Sper; 1959 Nov; 35():1373-5. PubMed ID: 13807117
    [No Abstract]   [Full Text] [Related]  

  • 8. Elimination of inhibition in euglobulin fibrinolysis by use of flufenamate: involvement of C1-inactivator.
    Kluft C
    Haemostasis; 1977; 6(6):351-69. PubMed ID: 611048
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Estimation upon euglobulin clot lysis time, fibrin plate methods, and their clinical value (author's transl)].
    Fujita S
    Rinsho Byori; 1974 Aug; 22(8):539-44. PubMed ID: 4473623
    [No Abstract]   [Full Text] [Related]  

  • 10. [Euglobulin lysis time (ELT)].
    Kaizu K; Abe M
    Nihon Rinsho; 2004 Dec; 62 Suppl 12():584-5. PubMed ID: 15658395
    [No Abstract]   [Full Text] [Related]  

  • 11. [On euglobulin fibrinolysis. I. The characteristics of euglobulin fibrinolysis in normal man].
    CAMERADA P; CONGIU M; LEO P
    Boll Soc Ital Biol Sper; 1959 Nov; 35():1370-3. PubMed ID: 13807116
    [No Abstract]   [Full Text] [Related]  

  • 12. [EFFECTS ON FIBRINOLYTIC ACTIVITY OF TOLBUTAMIDE ADDED "IN VITRO" TO PLASMA AND TO THE EUGLOBULIN FRACTION].
    BELLI C; TESSARI L
    Arch Sci Med (Torino); 1963 Oct; 116():181-7. PubMed ID: 14098152
    [No Abstract]   [Full Text] [Related]  

  • 13. [Euglobulin lysis time].
    Sakuragawa N
    Nihon Rinsho; 1997 Mar; 55 Suppl 1():139-44. PubMed ID: 9097575
    [No Abstract]   [Full Text] [Related]  

  • 14. [Kinetics of non-activated euglobulin fibrinolysis in human plasma].
    Hindersin P; Zwiener U; Fischer W
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1974; 101(2):293-9. PubMed ID: 4136394
    [No Abstract]   [Full Text] [Related]  

  • 15. C1-inactivator-resistant fibrinolytic activity in plasma euglobulin fractions: its relation to vascular activator in blood and its role in euglobulin fibrinolysis.
    Kluft C
    Thromb Res; 1978 Aug; 13(2):135-51. PubMed ID: 694838
    [No Abstract]   [Full Text] [Related]  

  • 16. [On the difference between serum and euglobulin in determination of fibrinolytic activities by streptokinase-activated method with special reference to the relationship with antiplasmin agents].
    Miyatani K; Fukui I
    Rinsho Byori; 1971 Mar; 19(3):223-6. PubMed ID: 4252723
    [No Abstract]   [Full Text] [Related]  

  • 17. [Effect of actomyosin on blood coagulation and fibrinolysis].
    Andreenko GV; Liutova LV
    Vopr Med Khim; 1976; 22(2):166-71. PubMed ID: 1030884
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [On euglobulin fibrinolysis. III. Primary data on the characteristics of euglobulin fibrinolysis in infective diseases and in neoplasms].
    CAMERADA P; CONGIU M; LEO P
    Boll Soc Ital Biol Sper; 1959 Nov; 35():1375-6. PubMed ID: 13807118
    [No Abstract]   [Full Text] [Related]  

  • 19. [The influence of atherosclerotic vascular tissue on the fibrinolytic and proteolytic activity of plasma].
    JANIAKOWA A
    Angeiologie; 1962; 14():31-4. PubMed ID: 13957341
    [No Abstract]   [Full Text] [Related]  

  • 20. [An evaluation of euglobulin clot lysis time (ELT) measurement with the time saving recorder (author's transl)].
    Amemiya Y; Amaki I; Ariga T; Sawai H; Oshiba S
    Rinsho Ketsueki; 1973 Oct; 14(10):1008-17. PubMed ID: 4796985
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.